The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2–infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.
- clinical research/practice
- immunosuppressive regimens
- infection and infectious agents—viral
- kidney transplantation/nephrology
ASJC Scopus subject areas
- Immunology and Allergy
- Pharmacology (medical)